National Research Corporation

NRC Healthcare Health Information Services

National Research Corporation’s revenue for fiscal 2025 (year ended December 2025) was $137.4 million, down 3.96% from fiscal 2024. In the quarter to June 2026, revenue grew 3.98%, EPS fell 3,091.5%, free cash flow grew 101.5% and total debt rose 11.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years; insiders bought in the last twelve months.

20.15 0.96 −4.55%
Market cap
$466.9M
P/E
80.6×
Fwd P/E
4.9×
Dividend yield
3.18%
F-score
6/9
Altman Z
3.33
Beneish M
−3.10
Dividend safety
45/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
86.28 42.95 37.15 18.12

+8 more quarters

P/S ratio
3.39 2.67 3.06 2.03
P/FCF ratio
21.94 21.24 26.69 24.34
P/Operating CF
342.52 51.55 58.52 20.55
P/B ratio
72.49 27.43 30.03 19.76
EV/Sales
3.98 3.19 3.57 2.56
EV/EBITDA
23.74 15.81 16.20 10.31
EV/FCF
25.76 25.34 31.19 30.69
Current Ratio
0.65 0.52 0.55 0.53
Net Debt/EBITDA
(75.86) 9.20 10.36 7.41
Debt/Equity
13.13 5.48 5.36 5.31
Earnings Yield
1.16% 2.33% 2.69% 5.52%
Free Cash Flow Yield
4.56% 4.71% 3.75% 4.11%
Free Cash Flow per Share
0.00 0.25 0.27 0.46
Book value per Share
0.30 0.62 0.63 0.65
Free Cash Flow
0.06 5.35 6.06 10.18
EV/EBIT
37.82 22.57 21.74 12.96
Other line items

Show all line items

Columns are period end dates